Management of Hemodynamically Unstable Monomorphic Ventricular Tachycardia
For hemodynamically unstable monomorphic VT, proceed immediately to synchronized direct-current cardioversion with 100 J without delay—this is a Class I recommendation and the only definitive first-line therapy. 1, 2
Defining Hemodynamic Instability
Before initiating treatment, rapidly assess for any of the following criteria that define instability: 1
- Systolic blood pressure < 90 mmHg
- Altered mental status or loss of consciousness
- Clinical signs of shock (cold extremities, poor perfusion)
- Acute heart failure manifestations (pulmonary edema, severe dyspnea)
- Ongoing chest pain suggesting myocardial ischemia
If any single criterion is present, the patient is unstable and requires immediate electrical cardioversion. 1
Immediate Electrical Cardioversion Protocol
Pre-Shock Preparation
- Provide immediate sedation if the patient is conscious but hypotensive, before delivering the shock. 1, 2
- Ensure proper synchronization to the R-wave peak; never deliver the shock on the T wave to avoid precipitating ventricular fibrillation. 1
Energy Settings
- Deliver an initial synchronized shock of 100 J for monomorphic VT with rates > 150 bpm. 1, 2
- If the first shock fails, escalate energy sequentially: 200 J → 300 J → 360 J. 1
- For polymorphic VT resembling ventricular fibrillation, use an unsynchronized defibrillation shock of 200 J instead. 1
Temporizing Measure
- When a defibrillator is not immediately available, a precordial thump may be attempted as a temporizing measure in witnessed, monitored VT while equipment is prepared. 1
Post-Cardioversion Management
Immediate Monitoring
- Continuously monitor for atrial or ventricular premature complexes immediately after cardioversion, as these ectopic beats can precipitate VT recurrence. 1
If VT Recurs After Cardioversion
- Administer intravenous amiodarone to prevent acute reinitiation: 1, 2, 3
- Loading dose: 150 mg IV over 10 minutes
- Maintenance infusion: 1 mg/min for 6 hours, then 0.5 mg/min thereafter
- For breakthrough episodes: repeat the 150 mg bolus over 10 minutes
Alternative for Refractory Cases
- If VT remains refractory to standard cardioversion and amiodarone, consider double sequential synchronized cardioversion using two defibrillators simultaneously, which may obviate the need for additional medications that worsen hypotension. 4
Critical Safety Considerations
Medications to Avoid
- Never administer calcium-channel blockers (verapamil, diltiazem) for wide-complex tachycardia in unstable patients with structural heart disease, as they can precipitate ventricular fibrillation and hemodynamic collapse (Class III—harmful). 1, 2, 5
- The only exception is confirmed left-ventricular fascicular VT (RBBB morphology with left axis deviation), where verapamil is safe. 1
Amiodarone Adverse Effects
- Monitor for hypotension during amiodarone infusion; slow the infusion rate and add vasopressor drugs, positive inotropic agents, or volume expansion as needed. 3
- Watch for bradycardia and AV block; slow or discontinue the infusion if these occur. 3
Special Clinical Contexts
Acute Myocardial Ischemia
- If ischemia is suspected or cannot be excluded, pursue urgent coronary angiography with revascularization after initial stabilization. 5
- Beta-blockers improve mortality in recurrent polymorphic VT with acute MI and should be administered once hemodynamically stable. 1
Incessant or Electrical Storm VT
- For VT that recurs despite cardioversion and antiarrhythmic therapy, consider urgent catheter ablation (Class I recommendation for scar-related heart disease with electrical storm). 1, 2
- Combination therapy with beta-blockers plus amiodarone is recommended for VT storm. 1
Common Pitfalls to Avoid
- Do not delay cardioversion to administer antiarrhythmic drugs first—electrical therapy is more effective and delays increase mortality risk. 1, 2
- Do not assume a wide-complex tachycardia is supraventricular; always treat as VT when uncertain to avoid catastrophic undertreatment. 1, 5
- Do not use procainamide in the unstable setting—it is contraindicated in severe heart failure and acute MI, and its hypotensive effects can worsen shock. 2, 6